Quick Answer
Catheter Precision, Inc. reported Research And Development Expense of $272.0 thousand for the year ending 2024.
- Catheter Precision, Inc. showed a decrease of -42.7% in Research And Development Expense from 2023 to 2024.
- This data is from Catheter Precision, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $413.0 thousand | Q1 2018: $286.0 thousand | Q2 2018: $1.02 million | Q3 2018: $224.0 thousand | Q1 2019: $1.53 million | Q2 2019: $979.0 thousand | Q3 2019: $1.18 million | Q1 2020: $1.30 million | Q2 2020: $1.95 million | Q3 2020: $2.31 million | Q1 2021: $2.75 million | Q2 2021: $2.83 million | Q3 2021: $2.94 million | Q1 2022: $3.12 million | Q2 2022: $2.40 million | Q3 2022: $727.0 thousand | Q1 2023: $240.0 thousand | Q2 2023: $134.0 thousand | Q3 2023: $112.0 thousand | Q1 2024: $37.0 thousand | Q2 2024: $81.0 thousand | Q3 2024: $63.0 thousand.
- Over the full 8 years of available data (2017 to 2024), Catheter Precision, Inc.'s Research And Development Expense has declined by 94.0%.
- Historical annual values: Fiscal year 2024: $272.0 thousand | Fiscal year 2023: $475.0 thousand | Fiscal year 2022: $6.39 million | Fiscal year 2021: $12.25 million | Fiscal year 2020: $8.96 million | Fiscal year 2019: $4.53 million | Fiscal year 2018: $2.78 million | Fiscal year 2017: $4.52 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: